Regeneron Pharmaceuticals (REGN.MX) Q1 2026 Earnings

30JanConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
158.89
186.9
214.91
242.93

Details

Expected EPS
187.36760650899998
Actual EPS
199.66232
Surprise EPS
12.29
Surprise Percent
+6.56%

Description

Regeneron Pharmaceuticals (REGN.MX) has reported earnings of 199.66232 per share for Q1 2026.

0 Comments

Share your thoughts